arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 6/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Transparency good bye - u-turn of EMA concerning drug trial data

    NEW ON THE MARKET

    Insulin degludec (TRESIBA) for diabetes mellitus

    REVIEW

    Tick-borne encephalitis (II)

    IN BRIEF

    Ivabradine (PROCOROLAN) - increase of cardiovascular complications in patients with angina pectoris

    Risk-benefit assessment of ambroxol (MUCOSOLVAN, generics) and bromhexin (BISOLVON, generics)

    US poison centers - red flag about electronic cigarettes

    Now after all: early benefit assessment of dimethyl fumarate

    Warning about Miracle Mineral Supplement (MMS) miracle cure
    free

    CURRENT ADR NETWORK REPORT

    ROLENIUM ELPENHALER (fluticasone propionate + salmeterol): use prone to errors

    SIDE EFFECTS

    Quetiapin (SEROQUEL, generics) - acute liver failure and ischemic colitis

    e a-t IN INTERNET

    Aspirin without benefit for primary prevention of heart attack and stroke

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles